These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3879248)

  • 21. Effect of mecillinam on Escherichia coli growth curves when given alone and associated with ampicillin.
    Yourassowsky E; van der Linden MP; Lismont MJ; Crokaert F; Glupczynski Y
    Scand J Infect Dis; 1986; 18(5):439-45. PubMed ID: 3535050
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Comparative activity of mecillinam and ampicillin singly and in combination in the urinary bladder model and experimental mouse model.
    Anderson JD; Eftekhar F; Cleeland R; Kramer MJ; Beskid G
    J Antimicrob Chemother; 1981 Aug; 8(2):121-31. PubMed ID: 6268599
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro activity of aminopenicillins combined with sulbactam, clavulanic acid, or amdinocillin against bacteria isolated from patients with complicated urinary tract infections.
    Naber KG; Wittenberger R
    Rev Infect Dis; 1986; 8 Suppl 5():S604-8. PubMed ID: 3026011
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Sensitivity of Enterobacteriaceae isolated from humans to 6-N,N-1',6'-hexyleneformamidine-penicillanic acid (preparation HX)].
    Zaremba M; Zukowska-Nytko K; Grala-Kałuzna A; Kacprzak-Wiatr A; Piotrowski J; Kulikowska A; borowski J
    Med Dosw Mikrobiol; 1982; 34(1-2):17-26. PubMed ID: 6292593
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro interaction between mecillinam and piperacillin-tazobactam in the presence of azithromycin against members of the Enterobacteriaceae family and Pseudomonas aeruginosa.
    Maioli E; Debbia EA; Gualco L; Marchese A
    New Microbiol; 2008 Jan; 31(1):37-46. PubMed ID: 18437840
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mecillinam, a novel penicillanic acid derivative with unusual activity against gram-negative bacteria.
    Neu HC
    Antimicrob Agents Chemother; 1976 May; 9(5):793-9. PubMed ID: 949176
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Activity of mecillinam alone and in combination with other beta-lactam antibiotics.
    Fass RJ
    Antimicrob Agents Chemother; 1980 Dec; 18(6):906-12. PubMed ID: 6263179
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Comparison of in vitro activities of eight new beta-lactam compounds against cephalothin-resistant Enterobacteriaceae from hospital patients.
    Costopoulos C; Legakis NJ; Papafragas E; Marinis E
    Chemotherapy; 1984; 30(3):158-64. PubMed ID: 6610538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro combination of mecillinam with cephradine or amoxycillin for organisms resistant to single agents.
    Chattopadhyay B; Hall I
    J Antimicrob Chemother; 1979 Sep; 5(5):549-53. PubMed ID: 227829
    [TBL] [Abstract][Full Text] [Related]  

  • 30. An in vitro evaluation of clavulanic acid, a potent, broad-spectrum beta-lactamase inhibitor.
    Greenwood D; O'Grady F; Baker P
    J Antimicrob Chemother; 1979 Sep; 5(5):539-47. PubMed ID: 387706
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In-vitro evaluation of ampicillin/brobactam and comparison with other beta-lactam antibiotics.
    Melchior NH; Keiding J
    J Antimicrob Chemother; 1991 Jan; 27(1):29-40. PubMed ID: 1646779
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Inducing capacity of the combinations mecillinam-ampicillin and mecillinam-ceftazidime in comparison with the capacity of the compounds administered separately.
    Stobberingh EE; van Boven CP
    Chemotherapy; 1987; 33(2):97-102. PubMed ID: 3552473
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative potency of mecillinam and other beta-lactam antibiotics against Escherichia coli strains producing different beta-lactamases.
    Sougakoff W; Jarlier V
    J Antimicrob Chemother; 2000 Sep; 46 Suppl 1():9-14; discussion 63-5. PubMed ID: 11051618
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Ceftazidime combined with mecillinam: serum bactericidal titres compared with in-vitro synergy against gram-negative bacilli.
    Van der Auwera P; Vandermies A; Lieppe S; Grenier P; Bourguignon AM; Ernst F
    J Antimicrob Chemother; 1988 Jun; 21(6):745-53. PubMed ID: 3045067
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Comparative evaluation of the in vitro activity of three combinations of beta-lactams with beta-lactamase inhibitors: piperacillin/tazobactam, ticarcillin/clavulanic acid and ampicillin/sulbactam.
    Sader HS; Tosin I; Sejas L; Miranda E
    Braz J Infect Dis; 2000 Feb; 4(1):22-8. PubMed ID: 10788842
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mecillinam/clavulanate combination: a possible option for the treatment of community-acquired uncomplicated urinary tract infections caused by extended-spectrum β-lactamase-producing Escherichia coli.
    Lampri N; Galani I; Poulakou G; Katsarolis I; Petrikkos G; Giamarellou H; Souli M
    J Antimicrob Chemother; 2012 Oct; 67(10):2424-8. PubMed ID: 22665388
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of the epidemiology of bacterial resistance to mecillinam and ampicillin.
    Anderson JD; Adams MA; Barrington JC; Spence WN; Sheperd CA
    Antimicrob Agents Chemother; 1976 Dec; 10(6):872-7. PubMed ID: 1051328
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mecillinam-ampicillin synergism in experimental Enterobacteriaceae meningitis.
    Scheld WM; Fink FN; Fletcher DD; Sande MA
    Antimicrob Agents Chemother; 1979 Sep; 16(3):271-6. PubMed ID: 228591
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Combined antimicrobial action of mecillinam and ampicillin].
    Khantimer EI
    Antibiotiki; 1983 Aug; 28(8):589-91. PubMed ID: 6314880
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative in vitro studies on the beta-lactamase-inhibiting effect of clavulanic acid and sulbactam on ampicillin-resistant Enterobacteriaceae.
    Grimm H
    Int J Antimicrob Agents; 1996 Apr; 6 Suppl():S9-S14. PubMed ID: 18611726
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.